drugset / Trial / NCT04012047

Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

NCT04012047

Completed 17 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindOther

Summary

To investigate the role of KATP channels in migraine with aura patients.

Timeline

Start
2019-07-09
Primary completion
2019-12-10
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levcromakalim Small molecule 0.05 mg Other

Indications